Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

2141-V11

Catalog No. T9901A-1567 Copy Product Info
🥰Excellent
2141-V11 is an anti-CD40 agonist antibody that is enhanced by binding to FcγRIIB. In vivo, 2141-V11 can initiate an effective tumor-specific T-cell response and is applicable in the study of BCG-unresponsive non-muscle-invasive bladder cancer.

2141-V11

Copy Product Info
🥰Excellent
Catalog No. T9901A-1567

2141-V11 is an anti-CD40 agonist antibody that is enhanced by binding to FcγRIIB. In vivo, 2141-V11 can initiate an effective tumor-specific T-cell response and is applicable in the study of BCG-unresponsive non-muscle-invasive bladder cancer.

2141-V11
Cas No. 2923542-55-4
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
2141-V11 is an anti-CD40 agonist antibody that is enhanced by binding to FcγRIIB. In vivo, 2141-V11 can initiate an effective tumor-specific T-cell response and is applicable in the study of BCG-unresponsive non-muscle-invasive bladder cancer.
Chemical Properties
Cas No.2923542-55-4
Storage & Solubility Information
StorageStore at -20°C Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy 2141-V11 | purchase 2141-V11 | 2141-V11 cost | order 2141-V11